Dr.ย Abrahamย Avigdor
MD, Board Certified โ Internal Medicine & Hematology
Co-Director, Division of Haematology & Bone Marrow Transplantation
corporate_fareSheba Medical Center, Tel Hashomer, Israel
Abraham Avigdor
MD, Board Certified โ Internal Medicine & Hematology
Prof. Abraham Avigdor is a senior haemato-oncologist at Sheba Medical Center, Tel Hashomer, Israel, where he serves as Co-Director of the Division of Haematology and Bone Marrow Transplantation. He holds Israeli board certifications in Internal Medicine and Haematology, and has been at the forefront of lymphoma care and cellular therapy research in Israel for more than three decades.
Prof. Avigdor received his MD from Ben-Gurion University in 1990 and completed his haematology and bone marrow transplantation training at Sheba Medical Center, where he has held senior roles ever since. He led Sheba's Lymphoma Service from 2005 to 2009 and served as Director of the Institute of Haematology from 2009 to 2020, before assuming his current role as Co-Director of the Division of Haematology and BMT from 2020. He also served as Chairman of the Israel Lymphoma Working Group from 2011 to 2017 and has held an appointment as Senior Lecturer at Tel Aviv University School of Medicine since 2014. Tel Aviv University's research portal lists 156 academic outputs in his name, covering lymphoma, CAR T-cell therapy, PET/CT in lymphoma assessment, and novel biological treatment strategies.
CancerFax can coordinate medical-report review and consultation support for international patients seeking an expert opinion from Prof. Avigdor at Sheba Medical Center.
Why Consider Prof. Abraham Avigdor?
Prof. Avigdor brings more than three decades of dedicated haematology and lymphoma expertise at one of Israel's leading tertiary medical centres, combined with an active research focus on cellular and immunological therapies for complex blood cancers.
Areas of Specialisation
Haematology, lymphoma management, and advanced cellular therapies for blood cancers
Prof. Avigdor's clinical and research focus centres on lymphoma in all its forms, bone marrow transplantation-related haematology, and the integration of modern cellular and immunological therapies into clinical practice. His expertise spans both the diagnostic and therapeutic dimensions of haematologic malignancies.
Lymphoma Management
Comprehensive evaluation and treatment planning for Hodgkin and non-Hodgkin lymphomas, including advanced-stage and relapsed or refractory disease.
- arrow_rightEvaluation and treatment planning for classical Hodgkin lymphoma
- arrow_rightPET/CT-guided response assessment and prognostic evaluation
- arrow_rightManagement of relapsed or refractory disease
- arrow_rightLarge B-cell lymphoma including relapsed and refractory cases
- arrow_rightMarginal zone lymphoma evaluation and systemic treatment planning
- arrow_rightBurkitt lymphoma including cases considered for cellular therapy
Cellular & Immunological Therapies
Research-led clinical expertise in CAR T-cell therapy and biological agent-based treatment approaches for lymphoma and multiple myeloma.
- arrow_rightIntegration of CAR T-cell therapy into non-Hodgkin lymphoma management
- arrow_rightCAR T-cell approaches for selected multiple myeloma cases
- arrow_rightEvaluation of CAR T-cell candidacy and treatment planning
- arrow_rightPI3K-inhibitor-based regimens for relapsed marginal zone lymphoma
- arrow_rightNewer immunological treatment regimens for lymphoid malignancies
- arrow_rightBiomarker-guided selection of biological agents where applicable
Bone Marrow Transplantation-Related Haematology
Clinical haematology support for patients requiring transplantation-related assessment, evaluation, and haematologic management.
- arrow_rightHaematologic evaluation for patients being considered for bone marrow transplantation
- arrow_rightPost-doctoral research training in human haematopoietic stem cell biology at Weizmann Institute
- arrow_rightLong-standing senior clinical role within Sheba's BMT division
Procedures Performed
Clinical services and haematology treatment approaches
Prof. Avigdor's clinical practice spans the full spectrum of haematology consultation, lymphoma evaluation, cellular therapy planning, and systemic haematologic treatment. His approach combines advanced diagnostics with modern biological and cellular treatment strategies.
Haematology Consultation & Lymphoma Evaluation
Medical OncologyComprehensive haematology review and lymphoma assessment including disease staging, biomarker-guided evaluation, and integrated treatment planning.
Systemic Lymphoma Treatment Planning
Targeted TherapyTreatment planning for systemic lymphoma therapies including biological agents, PI3K inhibitors, and immunological regimens for eligible patients.
Cellular Therapy Evaluation
Complex DiseaseAssessment and planning for CAR T-cell therapy candidacy in non-Hodgkin lymphoma and multiple myeloma.
Second Opinion for Lymphoma & Haematologic Malignancies
Second OpinionExpert review of diagnosis, pathology, staging, and treatment plan for patients with lymphoma or haematologic malignancies.
Research & Publications
Peer-reviewed contributions in lymphoma, haematology, and cellular therapy
Prof. Avigdor has an extensive academic research profile. Tel Aviv University's research portal lists 156 outputs in his name, covering lymphoma biology, CAR T-cell therapy, PET/CT-based prognostic assessment, and novel immunological treatment approaches for haematologic malignancies.
Tel Aviv University's research portal lists 156 academic outputs for Prof. Avigdor. A full publication list is available via PubMed and the Tel Aviv University CRIS portal.
Education & Training
Prof. Avigdor completed his MD at Ben-Gurion University in 1990, followed by internship, internal medicine residency, and haematology and bone marrow transplantation training at Sheba Medical Center. He holds Israeli board certifications in both Internal Medicine and Haematology, and completed post-doctoral research at the Weizmann Institute of Science.
Clinical Experience
Prof. Avigdor has spent his entire senior clinical career at Sheba Medical Center, progressing from Senior Haematology and BMT Physician to Head of the Lymphoma Service, Director of the Institute of Haematology, and now Co-Director of the Division of Haematology and Bone Marrow Transplantation. He concurrently holds a Senior Lecturer appointment at Tel Aviv University School of Medicine.
Languages & International
Prof. Avigdor consults in the following languages.
CancerFax can coordinate professional medical interpreter support for international patients who require consultation in languages other than English or Hebrew.
CancerFax can coordinate professional medical interpreter support for international patients when required.
How CancerFax Helps You Access Dr. Abraham Avigdor
CancerFax is a specialist cancer patient-navigation platform. We help international patients prepare structured medical summaries, assess treatment eligibility, and connect directly with Dr. Abraham Avigdor's team โ with full coordination from initial inquiry to consultation.
Medical Report Review
Free review of your pathology results, imaging, molecular profiling, and treatment history โ prepared as a structured clinical summary for Dr. Abraham Avigdor's team.
Treatment Eligibility Screening
CancerFax screens your case for eligibility for treatments and clinical programmes available through Dr. Abraham Avigdor before you travel, so you arrive with a clear pathway.
Case Submission
We coordinate direct case submission to Dr. Abraham Avigdor's department, including all documentation required for clinical review and appointment scheduling.
Appointment & Consultation Coordination
CancerFax manages appointment scheduling with Dr. Abraham Avigdor's team, confirming availability and aligning timelines with your travel plans.
Travel, Visa & Logistics Support
We prepare visa invitation letters, provide hospital-proximity accommodation guidance, and coordinate airport transfers for international patients.
Follow-Up & Continuity of Care
After your consultation or treatment, CancerFax facilitates communication between Dr. Abraham Avigdor's team and your home oncologist for seamless post-treatment follow-up.
Frequently Asked Questions About Prof. Abraham Avigdor
Prof. Avigdor specialises in haematology, haemato-oncology, lymphoma, and bone marrow transplantation-related haematology. His primary clinical focus is lymphoma, covering all major types including Hodgkin lymphoma, non-Hodgkin lymphoma, large B-cell lymphoma, marginal zone lymphoma, and Burkitt lymphoma. He also has an active research focus on CAR T-cell therapy for non-Hodgkin lymphoma and multiple myeloma.
Prof. Avigdor is associated with Sheba Medical Center, Tel Hashomer, Israel, one of the country's leading tertiary medical centres. He currently serves as Co-Director of the Division of Haematology and Bone Marrow Transplantation.
Sheba Medical Center lists Prof. Avigdor on its international-facing doctor pages and offers a consultation request pathway for international patients. CancerFax can coordinate medical-report review and case preparation to support international patients seeking an opinion from Prof. Avigdor, subject to hospital availability and case acceptance.
Submit your medical reports โ including pathology, imaging, treatment history, and relevant test results โ through CancerFax. The CancerFax team will review and prepare the case for submission, and coordinate the next steps with Sheba Medical Center, subject to availability.
Yes. Prof. Avigdor's current research focus includes integrating CAR T-cell therapy into modern management of non-Hodgkin lymphomas and multiple myeloma. He has published research on CAR T-cell infusion timing and outcomes in large B-cell lymphoma (Blood, 2026), and has earlier case-level contributions to CAR T-cell therapy in refractory Burkitt lymphoma.
Prof. Avigdor holds an MD from Ben-Gurion University, Israeli Board Certifications in Internal Medicine and Haematology, and completed post-doctoral research in immunology and haematopoietic stem cell biology at the Weizmann Institute of Science. He has been in senior haematology and BMT practice at Sheba Medical Center since 1998, giving him more than 25 years in senior haematology roles and more than 34 years of medical practice overall.
Connect with Abraham Avigdor Today
Share your medical reports for a free preliminary review. Our patient coordinators will help you understand your options and arrange a direct consultation.
Medical Disclaimer: Information on this page is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making any medical decisions.